癌バイオマーカーの世界市場動向・分析2018-2025

【英語タイトル】Global Cancer Biomarkers Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料(QYR8D01579)・商品コード:QYR8D01579
・発行会社(調査会社):QYResearch
・発行日:2018年10月26日(※2024年版があります。お問い合わせください)
・ページ数:116
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国
・産業分野:材料・化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,600 ⇒換算¥828,800見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD11,200 ⇒換算¥1,657,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、癌バイオマーカーの世界市場について調査・分析し、種類別には、プロテインバイオマーカー、Geneticバイオマーカー、その他に、用途別には、乳癌、肺癌、大腸癌、黒色腫、血液癌、前立腺癌、卵巣癌、胃癌、肝癌に区分してまとめました。調査対象企業は、Abbott Laboratories、Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd、Illumina,Inc.、Agilent Technologies、Qiagen NV、Merck & Co., Inc.、Hologic,Inc.、Novartis AG、BioMerieux SA、Genomic Health, Inc.、Affymetrix Inc.、Roche Diagnostics Ltd.等です。

・レポートの概要
・グローバル成長トレンド
・癌バイオマーカーの世界市場規模
・癌バイオマーカーの地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別癌バイオマーカーの価格動向
・癌バイオマーカーの種類別市場規模(プロテインバイオマーカー、Geneticバイオマーカー、その他)
・癌バイオマーカーの用途別市場規模(乳癌、肺癌、大腸癌、黒色腫、血液癌、前立腺癌、卵巣癌、胃癌、肝癌)
・癌バイオマーカーの北米市場(アメリカ、カナダ、メキシコ)
・癌バイオマーカーのヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・癌バイオマーカーのアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・癌バイオマーカーの中南米市場(ブラジル等)
・癌バイオマーカーの中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Abbott Laboratories、Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd、Illumina,Inc.、Agilent Technologies、Qiagen NV、Merck & Co., Inc.、Hologic,Inc.、Novartis AG、BioMerieux SA、Genomic Health, Inc.、Affymetrix Inc.、Roche Diagnostics Ltd.)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・癌バイオマーカーの市場規模予測
・癌バイオマーカーの種類別市場予測2018-2025(プロテインバイオマーカー、Geneticバイオマーカー、その他)
・癌バイオマーカーの用途別市場予測2018-2025(乳癌、肺癌、大腸癌、黒色腫、血液癌、前立腺癌、卵巣癌、胃癌、肝癌)
・癌バイオマーカーの北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・癌バイオマーカーのヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・癌バイオマーカーのアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・癌バイオマーカーの中南米市場予測2018-2025(ブラジル等)
・癌バイオマーカーの中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

This study focuses on the production side and consumption side of Cancer Biomarkers, presents the global Cancer Biomarkers market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.In terms of production side, this report researches the Cancer Biomarkers capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Cancer Biomarkers by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

The Cancer Biomarkers market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Cancer Biomarkers.

This report includes the following manufacturers; we can also add the other companies as you want.
Abbott Laboratories
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd
Illumina,Inc.
Agilent Technologies
Qiagen NV
Merck & Co., Inc.
Hologic,Inc.
Novartis AG
BioMerieux SA
Genomic Health, Inc.
Affymetrix Inc.
Roche Diagnostics Ltd.

Market Segment by Product Type
Protein Biomarkers
Genetic Biomarkers
Others

Market Segment by Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancer
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer

Key Regions split in this report:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa

The study objectives are:
To analyze and research the global Cancer Biomarkers status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Cancer Biomarkers manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Cancer Biomarkers are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Cancer Biomarkers Market Size Growth Rate by Type
1.3.2 Protein Biomarkers
1.3.3 Genetic Biomarkers
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Cancer Biomarkers Market Share by Application (2018-2025)
1.4.2 Breast Cancer
1.4.3 Lung Cancer
1.4.4 Colorectal Cancer
1.4.5 Melanoma
1.4.6 Blood Cancer
1.4.7 Prostate Cancer
1.4.8 Ovarian Cancer
1.4.9 Stomach Cancer
1.4.10 Liver Cancer
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Cancer Biomarkers Production Value 2013-2025
2.1.2 Global Cancer Biomarkers Production 2013-2025
2.1.3 Global Cancer Biomarkers Capacity 2013-2025
2.1.4 Global Cancer Biomarkers Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2018-2025
2.2.1 Global Cancer Biomarkers Market Size CAGR of Key Regions
2.2.2 Global Cancer Biomarkers Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Cancer Biomarkers Capacity by Manufacturers
3.1.2 Global Cancer Biomarkers Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Cancer Biomarkers Revenue by Manufacturers (2013-2018)
3.2.2 Cancer Biomarkers Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Cancer Biomarkers Market Concentration Ratio (CR5 and HHI)
3.3 Cancer Biomarkers Price by Manufacturers
3.4 Key Manufacturers Cancer Biomarkers Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Cancer Biomarkers Market
3.6 Key Manufacturers Cancer Biomarkers Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Protein Biomarkers Production and Production Value (2013-2018)
4.1.2 Genetic Biomarkers Production and Production Value (2013-2018)
4.1.3 Others Production and Production Value (2013-2018)
4.2 Global Cancer Biomarkers Production Market Share by Type
4.3 Global Cancer Biomarkers Production Value Market Share by Type
4.4 Cancer Biomarkers Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Cancer Biomarkers Consumption by Application

6 Production by Regions
6.1 Global Cancer Biomarkers Production (History Data) by Regions 2013-2018
6.2 Global Cancer Biomarkers Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Cancer Biomarkers Production Growth Rate 2013-2018
6.3.2 United States Cancer Biomarkers Production Value Growth Rate 2013-2018
6.3.3 Key Players in United States
6.3.4 United States Cancer Biomarkers Import & Export
6.4 Europe
6.4.1 Europe Cancer Biomarkers Production Growth Rate 2013-2018
6.4.2 Europe Cancer Biomarkers Production Value Growth Rate 2013-2018
6.4.3 Key Players in Europe
6.4.4 Europe Cancer Biomarkers Import & Export
6.5 China
6.5.3 Key Players in China
6.5.2 China Cancer Biomarkers Production Value Growth Rate 2013-2018
6.5.3 Key Players in China
6.5.4 China Cancer Biomarkers Import & Export
6.6 Japan
6.6.1 Japan Cancer Biomarkers Production Growth Rate 2013-2018
6.6.2 Japan Cancer Biomarkers Production Value Growth Rate 2013-2018
6.6.3 Key Players in Japan
6.6.4 Japan Cancer Biomarkers Import & Export
6.7 Other Regions
6.7.1 South Korea
6.7.2 India
6.7.3 Southeast Asia

7 Cancer Biomarkers Consumption by Regions
7.1 Global Cancer Biomarkers Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Cancer Biomarkers Consumption by Type
7.2.2 North America Cancer Biomarkers Consumption by Application
7.2.3 North America Cancer Biomarkers Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Cancer Biomarkers Consumption by Type
7.3.2 Europe Cancer Biomarkers Consumption by Application
7.3.3 Europe Cancer Biomarkers Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Cancer Biomarkers Consumption by Type
7.4.2 Asia Pacific Cancer Biomarkers Consumption by Application
7.4.3 Asia Pacific Cancer Biomarkers Consumption by Countries
7.4.4 China
7.4.5 Japan
7.4.6 Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Cancer Biomarkers Consumption by Type
7.5.2 Central & South America Cancer Biomarkers Consumption by Application
7.5.3 Central & South America Cancer Biomarkers Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Cancer Biomarkers Consumption by Type
7.6.2 Middle East and Africa Cancer Biomarkers Consumption by Application

8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Abbott Laboratories Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Cancer Biomarkers
8.1.4 Cancer Biomarkers Product Introduction
8.1.5 Abbott Laboratories Recent Development
8.2 Thermo Fisher Scientific Inc.
8.2.1 Thermo Fisher Scientific Inc. Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Cancer Biomarkers
8.2.4 Cancer Biomarkers Product Introduction
8.2.5 Thermo Fisher Scientific Inc. Recent Development
8.3 F. Hoffmann-La Roche Ltd
8.3.1 F. Hoffmann-La Roche Ltd Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Cancer Biomarkers
8.3.4 Cancer Biomarkers Product Introduction
8.3.5 F. Hoffmann-La Roche Ltd Recent Development
8.4 Illumina,Inc.
8.4.1 Illumina,Inc. Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Cancer Biomarkers
8.4.4 Cancer Biomarkers Product Introduction
8.4.5 Illumina,Inc. Recent Development
8.5 Agilent Technologies
8.5.1 Agilent Technologies Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Cancer Biomarkers
8.5.4 Cancer Biomarkers Product Introduction
8.5.5 Agilent Technologies Recent Development
8.6 Qiagen NV
8.6.1 Qiagen NV Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Cancer Biomarkers
8.6.4 Cancer Biomarkers Product Introduction
8.6.5 Qiagen NV Recent Development
8.7 Merck & Co., Inc.
8.7.1 Merck & Co., Inc. Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Cancer Biomarkers
8.7.4 Cancer Biomarkers Product Introduction
8.7.5 Merck & Co., Inc. Recent Development
8.8 Hologic,Inc.
8.8.1 Hologic,Inc. Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Cancer Biomarkers
8.8.4 Cancer Biomarkers Product Introduction
8.8.5 Hologic,Inc. Recent Development
8.9 Novartis AG
8.9.1 Novartis AG Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Cancer Biomarkers
8.9.4 Cancer Biomarkers Product Introduction
8.9.5 Novartis AG Recent Development
8.10 BioMerieux SA
8.10.1 BioMerieux SA Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Cancer Biomarkers
8.10.4 Cancer Biomarkers Product Introduction
8.10.5 BioMerieux SA Recent Development
8.11 Genomic Health, Inc.
8.12 Affymetrix Inc.
8.13 Roche Diagnostics Ltd.

9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Cancer Biomarkers Capacity, Production Forecast 2018-2025
9.1.2 Global Cancer Biomarkers Production Value Forecast 2018-2025
9.2 Cancer Biomarkers Production and Production Value Forecast by Regions
9.2.1 Global Cancer Biomarkers Production Value Forecast by Regions
9.2.2 Global Cancer Biomarkers Production Forecast by Regions
9.3 Cancer Biomarkers Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.3.5 Other Regions
9.4 Forecast by Type
9.4.1 Global Cancer Biomarkers Production Forecast by Type
9.4.2 Global Cancer Biomarkers Production Value Forecast by Type

10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Cancer Biomarkers Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Cancer Biomarkers Consumption Forecast by Countries 2018-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Cancer Biomarkers Consumption Forecast by Countries 2018-2025
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Cancer Biomarkers Consumption Forecast by Countries 2018-2025
10.5.2 China
10.5.3 Japan
10.5.4 Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Cancer Biomarkers Consumption Forecast by Country 2018-2025
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Cancer Biomarkers Consumption Forecast by Countries 2018-2025
10.7.2 Middle East and Africa
10.7.3 GCC Countries
10.7.4 Egypt
10.7.5 South Africa

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Cancer Biomarkers Sales Channels
11.2.2 Cancer Biomarkers Distributors
11.3 Cancer Biomarkers Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis
12.4 Macroscopic Indicator
12.4.1 GDP for Major Regions
12.4.2 Price of Raw Materials in Dollars: Evolution

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

List of Tables and Figures

Figure Cancer Biomarkers Product Picture
Table Cancer Biomarkers Key Market Segments
Table Major Manufacturers Cancer Biomarkers Covered in This Report
Table Global Cancer Biomarkers Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Cancer Biomarkers Sales Market Shar by Type 2013-2025
Figure Protein Biomarkers Figures
Table Major Manufacturers of Protein Biomarkers
Figure Genetic Biomarkers Figures
Table Major Manufacturers of Genetic Biomarkers
Figure Others Figures
Table Major Manufacturers of Others
Table Global Cancer Biomarkers Market Share by Application 2018-2025 (K Units)
Figure Breast Cancer Use Case
Figure Lung Cancer Use Case
Figure Colorectal Cancer Use Case
Figure Melanoma Use Case
Figure Blood Cancer Use Case
Figure Prostate Cancer Use Case
Figure Ovarian Cancer Use Case
Figure Stomach Cancer Use Case
Figure Liver Cancer Use Case
Figure Cancer Biomarkers Report Years Considered
Figure Global Cancer Biomarkers Production Value Growth Rate 2013-2025 (Million US$)
Figure Global Cancer Biomarkers Production 2013-2025 (K Units)
Figure Global Cancer Biomarkers Capacity 2013-2025 (K Units)
Table Key Manufacturers Cancer Biomarkers Capacity (K Units)
Figure Global Cancer Biomarkers Price 2013-2025 (USD/Unit)
Table Global Cancer Biomarkers Market Size of Key Regions (Million USD) & (K Units)
Table Global Cancer Biomarkers Growth Rate of Key Regions 2018-2025 (Million USD)
Table Global Cancer Biomarkers Market Share for of Regions 2018-2025 (K Units)
Table Market Top Trends
Table Global Cancer Biomarkers Capacity by Manufacturers (2013-2018) (K Units)
Table Global Cancer Biomarkers Capacity Market Share by Manufacturers (2013-2018)
Table Global Cancer Biomarkers Production by Manufacturers (2013-2018) (K Units)
Table Global Cancer Biomarkers Production Share by Manufacturers (2013-2018)
Figure Global Cancer Biomarkers Production Share by Manufacturers in 2017
Table Cancer Biomarkers Revenue by Manufacturers (2013-2018) (Million USD)
Table Cancer Biomarkers Revenue Share by Manufacturers (2013-2018)
Figure Cancer Biomarkers Value Share by Manufacturers in 2017
Table Global Cancer Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Cancer Biomarkers Price by Manufacturers 2013-2018 (USD/Unit)
Table Key Manufacturers Cancer Biomarkers Plants/Factories Distribution
Table Key Manufacturers Cancer Biomarkers Area Served
Table Date of Key Manufacturers Enter into Cancer Biomarkers Market
Table Key Manufacturers Cancer Biomarkers Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Protein Biomarkers Production and Production Value (2013-2018) (K Units) & (Million US$)
Table Global Genetic Biomarkers Production and Production Value (2013-2018) (K Units) & (Million US$)
Table Global Others Production and Production Value (2013-2018) (K Units) & (Million US$)
Table Global Cancer Biomarkers Production by Type (2013-2018) (K Units)
Table Global Cancer Biomarkers Production Share by Type (2013-2018)
Figure Global Cancer Biomarkers Production Market Share by Type (2013-2018)
Figure Global Cancer Biomarkers Production Market Share by Type in 2017
Table Global Cancer Biomarkers Production Value by Type (2013-2018) (Million US$)
Table Global Cancer Biomarkers Production Value Share by Type (2013-2018)
Figure Global Cancer Biomarkers Production Value Market Share by Type (2013-2018)
Figure Global Cancer Biomarkers Production Value Market Share by Type in 2017
Table Cancer Biomarkers Ex-factory Price by Type 2013-2018 (USD/Unit)
Table Global Cancer Biomarkers Consumption by Application (2013-2018) (K Units)
Table Global Cancer Biomarkers Consumption Share by Application (2013-2018)
Figure Global Consumption Cancer Biomarkers Market Share by Application (2013-2018)
Table Global Cancer Biomarkers Production by Regions 2013-2018 (K Units)
Table Global Cancer Biomarkers Production Market Share by Regions 2013-2018
Figure Global Cancer Biomarkers Production Market Share by Regions 2013-2018
Figure Global Cancer Biomarkers Production Market Share by Regions in 2017
Table Global Cancer Biomarkers Production Value by Regions 2013-2018 (Million USD)
Table Global Cancer Biomarkers Production Value Market Share by Regions 2013-2018
Figure Global Cancer Biomarkers Production Value Market Share by Regions 2013-2018
Figure Global Cancer Biomarkers Production Value Market Share by Regions in 2017
Table United States Cancer Biomarkers Production and Value 2013-2018 (K Units) & (Million USD)
Figure United States Cancer Biomarkers Production Growth Rate 2013-2018 (K Units)
Figure United States Cancer Biomarkers Production Value Growth Rate 2013-2018 (Million USD)
Table United States Cancer Biomarkers Import & Export (K Units)
Table Europe Cancer Biomarkers Production and Value 2013-2018 (K Units) & (Million USD)
Figure Europe Cancer Biomarkers Production Growth Rate 2013-2018 (K Units)
Figure Europe Cancer Biomarkers Production Value Growth Rate 2013-2018 (Million USD)
Table Europe Cancer Biomarkers Import & Export (K Units)
Table China Cancer Biomarkers Production and Value 2013-2018 (K Units) & (Million USD)
Figure China Cancer Biomarkers Production Growth Rate 2013-2018 (K Units)
Figure China Cancer Biomarkers Production Value Growth Rate 2013-2018 (Million USD)
Table China Cancer Biomarkers Import & Export (K Units)
Table Japan Cancer Biomarkers Production and Value 2013-2018 (K Units) & (Million USD)
Figure Japan Cancer Biomarkers Production Growth Rate 2013-2018 (K Units)
Figure Japan Cancer Biomarkers Production Value Growth Rate 2013-2018 (Million USD)
Table Japan Cancer Biomarkers Import & Export (K Units)
Table Global Cancer Biomarkers Consumption by Regions 2013-2018 (K Units)
Table Global Cancer Biomarkers Consumption Market Share by Regions 2013-2018
Figure Global Cancer Biomarkers Consumption Market Share by Regions 2013-2018
Figure Global Cancer Biomarkers Consumption Market Share by Regions in 2017
Figure North America Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Table North America Cancer Biomarkers Consumption by Type (2013-2018) (K Units)
Figure North America Cancer Biomarkers Consumption Market Share by Type in 2018
Table North America Cancer Biomarkers Consumption by Application (2013-2018) (K Units)
Figure North America Cancer Biomarkers Consumption Market Share by Application in 2018
Table North America Cancer Biomarkers Consumption by Countries (2013-2018) (K Units)
Figure North America Cancer Biomarkers Consumption Market Share by Countries in 2018
Figure United States Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Canada Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Mexico Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Europe Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Table Europe Cancer Biomarkers Consumption by Type (2013-2018) (K Units)
Figure Europe Cancer Biomarkers Consumption Market Share by Type in 2018
Table Europe Cancer Biomarkers Consumption by Application (2013-2018) (K Units)
Figure Europe Cancer Biomarkers Consumption Market Share by Application in 2018
Table Europe Cancer Biomarkers Consumption by Countries (2013-2018) (K Units)
Figure Europe Cancer Biomarkers Consumption Market Share by Countries in 2018
Figure Germany Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure France Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure UK Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Italy Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Russia Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Table Asia Pacific Cancer Biomarkers Consumption by Type (2013-2018) (K Units)
Figure Asia Pacific Cancer Biomarkers Consumption Market Share by Type in 2018
Table Asia Pacific Cancer Biomarkers Consumption by Application (2013-2018) (K Units)
Figure Asia Pacific Cancer Biomarkers Consumption Market Share by Application in 2018
Table Asia Pacific Cancer Biomarkers Consumption by Countries (2013-2018) (K Units)
Table Asia Pacific Cancer Biomarkers Consumption Market Share by Countries (2013-2018)
Figure China Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Japan Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Korea Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure India Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Australia Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Indonesia Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Thailand Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Malaysia Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Philippines Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Vietnam Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Central & South America Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Table Central & South America Cancer Biomarkers Consumption by Type (2013-2018) (K Units)
Figure Central & South America Cancer Biomarkers Consumption Market Share by Type in 2018
Table Central & South America Cancer Biomarkers Consumption by Application (2013-2018) (K Units)
Figure Central & South America Cancer Biomarkers Consumption Market Share by Application in 2018
Table Central & South America Cancer Biomarkers Consumption by Countries (2013-2018) (K Units)
Figure Central & South America Cancer Biomarkers Consumption Market Share by Countries
Figure Brazil Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Cancer Biomarkers Consumption Growth Rate (2013-2018) (K Units)
Table Middle East and Africa Cancer Biomarkers Consumption by Type (2013-2018) (K Units)
Figure 2017 Middle East and Africa Cancer Biomarkers Consumption Market Share by Type
Table Middle East and Africa Cancer Biomarkers Consumption by Application (2013-2018) (K Units)
Figure 2017 Middle East and Africa Cancer Biomarkers Consumption Market Share by Application
Table Abbott Laboratories Company Details
Table Abbott Laboratories Description and Business Overview
Table Abbott Laboratories Cancer Biomarkers Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Abbott Laboratories Cancer Biomarkers Production Growth Rate (2013-2018)
Table Abbott Laboratories Cancer Biomarkers Production Market Share in Global Market
Table Abbott Laboratories Recent Development
Table Thermo Fisher Scientific Inc. Company Details
Table Thermo Fisher Scientific Inc. Description and Business Overview
Table Thermo Fisher Scientific Inc. Cancer Biomarkers Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Thermo Fisher Scientific Inc. Cancer Biomarkers Production Growth Rate (2013-2018)
Table Thermo Fisher Scientific Inc. Cancer Biomarkers Production Market Share in Global Market
Table Thermo Fisher Scientific Inc. Recent Development
Table F. Hoffmann-La Roche Ltd Company Details
Table F. Hoffmann-La Roche Ltd Description and Business Overview
Table F. Hoffmann-La Roche Ltd Cancer Biomarkers Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table F. Hoffmann-La Roche Ltd Cancer Biomarkers Production Growth Rate (2013-2018)
Table F. Hoffmann-La Roche Ltd Cancer Biomarkers Production Market Share in Global Market
Table F. Hoffmann-La Roche Ltd Recent Development
Table Illumina,Inc. Company Details
Table Illumina,Inc. Description and Business Overview
Table Illumina,Inc. Cancer Biomarkers Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Illumina,Inc. Cancer Biomarkers Production Growth Rate (2013-2018)
Table Illumina,Inc. Cancer Biomarkers Production Market Share in Global Market
Table Illumina,Inc. Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Description and Business Overview
Table Agilent Technologies Cancer Biomarkers Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Agilent Technologies Cancer Biomarkers Production Growth Rate (2013-2018)
Table Agilent Technologies Cancer Biomarkers Production Market Share in Global Market
Table Agilent Technologies Recent Development
Table Qiagen NV Company Details
Table Qiagen NV Description and Business Overview
Table Qiagen NV Cancer Biomarkers Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Qiagen NV Cancer Biomarkers Production Growth Rate (2013-2018)
Table Qiagen NV Cancer Biomarkers Production Market Share in Global Market
Table Qiagen NV Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Description and Business Overview
Table Merck & Co., Inc. Cancer Biomarkers Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Merck & Co., Inc. Cancer Biomarkers Production Growth Rate (2013-2018)
Table Merck & Co., Inc. Cancer Biomarkers Production Market Share in Global Market
Table Merck & Co., Inc. Recent Development
Table Hologic,Inc. Company Details
Table Hologic,Inc. Description and Business Overview
Table Hologic,Inc. Cancer Biomarkers Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Hologic,Inc. Cancer Biomarkers Production Growth Rate (2013-2018)
Table Hologic,Inc. Cancer Biomarkers Production Market Share in Global Market
Table Hologic,Inc. Recent Development
Table Novartis AG Company Details
Table Novartis AG Description and Business Overview
Table Novartis AG Cancer Biomarkers Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Novartis AG Cancer Biomarkers Production Growth Rate (2013-2018)
Table Novartis AG Cancer Biomarkers Production Market Share in Global Market
Table Novartis AG Recent Development
Table BioMerieux SA Company Details
Table BioMerieux SA Description and Business Overview
Table BioMerieux SA Cancer Biomarkers Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table BioMerieux SA Cancer Biomarkers Production Growth Rate (2013-2018)
Table BioMerieux SA Cancer Biomarkers Production Market Share in Global Market
Table BioMerieux SA Recent Development
Table Genomic Health, Inc. Company Details
Table Affymetrix Inc. Company Details
Table Roche Diagnostics Ltd. Company Details
Table Global Cancer Biomarkers Capacity, Production Forecast 2018-2025 (K Units)
Figure Global Cancer Biomarkers Capacity Forecast 2018-2025 (K Units)
Figure Global Cancer Biomarkers Production Forecast 2018-2025 (K Units)
Figure Global Cancer Biomarkers Production Value Forecast 2018-2025 (Million US$)
Table Global Cancer Biomarkers Revenue Forecast 2018-2025 (Million US$)
Table Global Cancer Biomarkers Production Value Forecast by Regions 2018-2025 (Million US$)
Figure Global Cancer Biomarkers Production Value Forecast by Regions 2018-2025 (Million US$)
Figure Global Cancer Biomarkers Production Value Market Share Forecast by Regions 2018-2025
Table Global Cancer Biomarkers Production Forecast by Regions 2018-2025 (K Units)
Figure Global Cancer Biomarkers Production Forecast by Regions 2018-2025 (K Units)
Figure Global Cancer Biomarkers Production Market Share Forecast by Regions 2018-2025
Table United States Cancer Biomarkers Production and Value Forecast 2018-2025 (K Units) & (Million US$)
Figure United States Cancer Biomarkers Production Forecast 2018-2025 (K Units)
Figure United States Cancer Biomarkers Revenue Forecast 2018-2025 (Million US$)
Table Europe Cancer Biomarkers Production and Value Forecast 2018-2025 (K Units) & (Million US$)
Figure Europe Cancer Biomarkers Production Forecast 2018-2025 (K Units)
Figure Europe Cancer Biomarkers Revenue Forecast 2018-2025 (Million US$)
Table China Cancer Biomarkers Production and Value Forecast 2018-2025 (K Units) & (Million US$)
Figure China Cancer Biomarkers Production Forecast 2018-2025 (K Units)
Figure China Cancer Biomarkers Revenue Forecast 2018-2025 (Million US$)
Table Japan Cancer Biomarkers Production and Value Forecast 2018-2025 (K Units) & (Million US$)
Figure Japan Cancer Biomarkers Production Forecast 2018-2025 (K Units)
Figure Japan Cancer Biomarkers Revenue Forecast 2018-2025 (Million US$)
Table Global Cancer Biomarkers Production Forecast by Type 2018-2025 (K Units)
Figure Global Cancer Biomarkers Production Forecast by Type 2018-2025 (K Units)
Figure Global Cancer Biomarkers Production Market Share Forecast by Type 2018-2025
Table Global Cancer Biomarkers Production Value Forecast by Type 2018-2025 (Million US$)
Figure Global Cancer Biomarkers Production Value Forecast by Type 2018-2025 (Million US$)
Figure Global Cancer Biomarkers Production Value Market Share Forecast by Type 2018-2025
Table Global Cancer Biomarkers Consumption Forecast by Application 2018-2025 (K Units)
Figure Global Cancer Biomarkers Consumption Forecast by Application 2018-2025 (K Units)
Figure Global Cancer Biomarkers Consumption Market Share Forecast by Application 2018-2025
Table Global Cancer Biomarkers Consumption Forecast by Regions 2018-2025 (K Units)
Figure Global Cancer Biomarkers Consumption Forecast by Regions 2018-2025 (K Units)
Figure Global Cancer Biomarkers Consumption Market Share Forecast by Regions 2018-2025
Table North America Cancer Biomarkers Consumption Forecast by Regions 2018-2025 (K Units)
Figure United States Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure Canada Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure MexicoCancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Table Europe Cancer Biomarkers Consumption Forecast by Regions 2018-2025 (K Units)
Figure Germany Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure France Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure UK Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure Italy Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure Russia Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Table Asia Pacific Cancer Biomarkers Consumption Forecast by Regions 2018-2025 (K Units)
Figure China Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure Japan Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure Korea Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure India Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure Australia Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure Indonesia Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure Thailand Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure Malaysia Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure Philippines Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure Vietnam Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Table Central & South America Cancer Biomarkers Consumption Forecast by Regions 2018-2025 (K Units)
Figure Brazil Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Table Middle East and Africa Cancer Biomarkers Consumption Forecast by Regions 2018-2025 (K Units)
Figure Middle East and Africa Cancer Biomarkers Consumption Forecast 2018-2025 (K Units)
Figure GCC Countries Cancer Biomarkers Sales Growth Rate (2018-2025) (K Units)
Figure Egypt Cancer Biomarkers Sales Growth Rate (2018-2025) (K Units)
Figure South Africa Cancer Biomarkers Sales Growth Rate (2018-2025) (K Units)
Figure Cancer Biomarkers Value Chain
Table Cancer Biomarkers Distributors List
Table Cancer Biomarkers Customers List
Table Porter's Five Forces Analysis
Figure GDP for Major Regions in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Figure Price of raw materials in dollars: Evolution
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Abbott Laboratories、Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd、Illumina,Inc.、Agilent Technologies、Qiagen NV、Merck & Co., Inc.、Hologic,Inc.、Novartis AG、BioMerieux SA、Genomic Health, Inc.、Affymetrix Inc.、Roche Diagnostics Ltd.

★調査レポート[癌バイオマーカーの世界市場動向・分析2018-2025] (コード:QYR8D01579)販売に関する免責事項を必ずご確認ください。
★調査レポート[癌バイオマーカーの世界市場動向・分析2018-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆